Intimation of Closure of Trading Window for the quarter ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has informed BSE that its trading window for dealing in the company's shares will be closed for directors, connected persons, and designated persons starting Thursday, January 1, 2026. The window will remain shut until 48 hours after the company declares its unaudited standalone financial results for the quarter ended December 31, 2025 (Q3 FY26). This is a routine compliance measure under SEBI's Insider Trading Regulations to prevent trading by those with access to unpublished financial information. The date of the board meeting to approve the Q3 results will be announced separately.
No direct impact on shareholders — this is a standard regulatory compliance notice. Investors can expect an upcoming earnings announcement (Q3 FY26 results) in January 2026, after which the trading window will reopen roughly 48 hours later.